Grants for Public and State controlled institutions of higher education - Food and Nutrition

This funding opportunity supports independent research projects in health-related fields for a wide range of eligible applicants, including universities, nonprofits, and small businesses, without allowing clinical trials.

This grant provides funding for research and training projects that help protect Michigan's horticulture industry from pests and safeguard plant products.

The Georgia Council for the Arts is excited to announce the 2024 Vibrant Communities Grants to support single art projects such as an art exhibit, a theatre production, a series of workshops for children, or an artist residency. Donor Name: Georgia Council for the Arts State: Georgia County: Selected Counties Type of Grant: Grant Deadline: 08/30/2024 Size of the Grant: $1000 to $10,000 Grant Duration: Less than 1 Year Details: The Georgia Legislature allocated funds to GCA specifically to increase the reach of arts grants across the state. These grants are intended to fund arts programs in as many counties as possible. Some examples of projects that could be funded by the Vibrant Communities grant are concerts, theatre productions, class field trips, art exhibits, murals, art festivals, or art classes. In addition, due to the ongoing impact of COVID on arts programs, GCA is including online programs to the list of program types eligible for Vibrant Communities Grant funding. Funding Information Vibrant Communities Grant applicants may request no more than $5,000 and no less than $1,000. Project Period Propose an arts project that will be completed between October 15, 2024 and June 1, 2025. Eligible Projects Eligible projects could include, but are not limited to: performances (theatre, dance, music, musical theatre, opera, storytelling, puppetry, and performance art; may be in person or virtual) art exhibits (two-dimensional, three-dimensional, photography, and digital) media arts presentations (film, video, and audio literary arts readings (poetry, fiction, and creative nonfiction) folk & traditional arts performances or exhibitions (music, dance, theatre, storytelling, and crafts) public art (murals and sculpture) outdoor performances arts festivals multidisciplinary arts projects education in any of the arts fields referenced above, including workshops, classes, demonstrations, and field trips artist residencies (in person or virtual) arts integration STEAM (arts integration of Science, Technology, Engineering, Arts, and Math) in-school (or virtual) programs for students transportation and admission for field trips (must be within the applicant’s county) a classroom residency by an artist (in person or virtual) arts programs with seniors (in person or virtual) arts programs with Veterans or military populations (in person or virtual) arts programs in hospitals or residential care facilities arts programs with incarcerated individuals professional development related to arts program development or arts management (in person or virtual) capacity building for arts programs or arts organizations (in person or virtual), such as hiring a consultant to address specific organizational needs (creating a strategic plan/development plan; Diversity, Equity and Inclusion initiatives, etc.) Eligibility Criteria Eligible organizations located within the following counties may apply: Atkinson, Bacon, Baker, Banks, Barrow, Bartow, Ben Hill, Berrien, Bleckley, Brantley, Brooks, Bryan, Burke, Butts, Calhoun, Candler, Catoosa, Charlton, Chattahoochee, Clay, Clayton, Clinch. Coffee, Columbia, Cook, Coweta, Crawford, Crisp, Dade, Dawson, Decatur, Dodge, Dooly, Early, Echols, Effingham, Elbert, Emanuel, Evans, Franklin, Glascock, Gordon, Grady, Habersham, Hall, Hancock, Haralson, Harris, Hart, Heard, Houston, Irwin, Jasper, Jeff Davis, Jefferson, Jenkins, Johnson, Jones, Lamar, Lanier, Laurens, Lee, Liberty, Lincoln, Long, Macon, Madison, Marion, McDuffie, McIntosh, Meriwether, Miller, Mitchell, Monroe, Montgomery, Murray, Oglethorpe, Paulding, Peach, Pickens, Pierce, Polk, Pulaski, Quitman, Randolph, Schley, Screven, Seminole, Spalding, Stewart, Sumter, Talbot, Taliaferro, Tattnall, Taylor,  Terrell, Towns, Treutlen, Turner, Twiggs, Upson, Walker, Warren, Washington, Wayne, Webster, Wheeler, Wilcox, Wilkinson, Worth An eligible applicant organization must be physically located in one of the Georgia counties listed above and must be one of the following: A non-profit organization that has been designated as a 501(c)3 organization by the IRS and is registered with the Georgia Secretary of State A local government entity (state and federal government entities are not eligible to apply) A public library A school, college or university Eligible Applications Eligible Applications must: Propose an arts project that will take place within the county in which the applicant is located. Include a 50% cash match for the grant request amount in the budget. Not include programming that promotes a specific religious doctrine or political party or candidate. Be the only application from an eligible organization. Multiple applications from the same applicant will not be considered for funding. For more information, visit GCA.

This funding opportunity supports institutions in creating collaborative training networks for early-career researchers focused on advancing studies in kidney, urologic, and hematologic diseases.

This funding opportunity provides substantial financial support to higher education institutions and nonprofit organizations to establish collaborative centers that advance research and resources for HIV/AIDS.

This grant provides funding to support small farmers and public entities in Maryland to aggregate local food products for sale to wholesale and institutional markets, enhancing the local food system.

This funding opportunity provides financial support to schools and school districts to conduct a pilot study aimed at reducing harmful contaminants in meals served to students and improving their nutritional quality.

The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization may be submitted to this FOA. This assumes such a change is programmatically permitted for the particular grant. Applications for change of recipient organization are considered prior approval requests (as described in Section 8.1.2.7 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although requests for change of recipient organization may be submitted through this FOA, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.

Modified release (MR) oral drug products are considered to have a high risk for alcohol dose dumping (ADD) because they contain large quantities of drug(s), designed to release over a prolonged period of time. Accidental exposure of these products to alcohol can result in the relatively rapid release of large quantities of drug with severe side effects, including death. To mitigate this risk, the FDA recommends conducting an in vitro alcohol dose dumping assessment in 0%, 5%, 20%, and 40% alcoholic dissolution media for all prospective generic versions of MR oral drug products. To date, ADD assessments have not been harmonized globally. For instance, the U.S. FDA recommends testing up to 40% alcoholic media while the European Medicines Agency recommends testing up to 20% alcoholic media. This type of difference can present a challenge for formulators designing products for multiple markets, as historical data has shown release from MR oral products do not always follow a linear response (either increasing or decreasing) to increasing alcohol concentrations. In addition, interpretation of an ADD assessment may be limited by the inability of the test to predict in vivo behavior. The purpose of this research is to develop tools that 1) facilitate the development of MR generic drug products that have a low potential for ADD, 2) support regulatory decision making during the assessment of such products, and 3) provide evidence that enables FDA to develop more specific recommendations for efficiently demonstrating a low or comparative potential of alcohol dose dumping for MR oral drug products containing high risk drugs.

This funding opportunity supports researchers in discovering and validating new targets for developing safe and effective pain treatments with minimal side effects and low addiction risk.

The HealthTech Accelerator is a 90-day tech business accelerator exclusively for pre-Series A HealthTech startups focused on Digital Health, Healthcare Services, Health Sustainability and Wellness, Medical Devices and Equipment, Software, Femtech, Augumented Reality, Virtual Reality, PharmacyTech, Wearables and Quantified Self, etc. Donor Name: Tampa Bay Wave State: Florida City: Tampa Type of Grant: Program Deadline: 05/24/2024 Size of the Grant: Not Available Grant Duration: Less than 1 Year Details: HealthTech|X is the latest startup focused business accelerator launched by Tampa Bay Wave, a nationally-recognized nonprofit, in partnership with the University of South Florida Research & Innovation, The Florida High Tech Corridor, U.S. Economic Development Corporation and more. Other Wave partnerships include Accenture, hospitals and health systems, healthcare specific VC funds, JP Morgan Chase, Bank of America, Raymond James, and more. Selected companies are not required to relocate for the duration of the program but must plan for on-site participation in Tampa, FL during each of the three blocks of programming.  Criteria for Consideration Business built with proprietary technology creating the next-generation of health technology products & solutions Dedicated management of at least two full-time people Ability to travel to Tampa at least 3 times during the 90-day program Proof of market validation Investable and/or scalable business Viable business plan Financial runaway of at least 6-12 months. For more information, visit Tampa Bay Wave.

The Toxics Use Reduction Institute (TURI) is pleased to invite proposals from academic faculty for funding to identify, evaluate, and/or develop safer alternatives to PFAS. Donor Name: Toxics Use Reduction Institute State: Massachusetts County: All Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 06/30/2024 Size of the Grant: $10,000 to $100,000 Grant Duration: Grant Duration Not Mentioned Details: Research Focus Area  Per- and polyfluoroalkyl substances (PFAS) are toxic chemicals used for a variety of manufacturing and product applications. Proposals should be submitted to identify, evaluate, and/or develop safer alternatives to the use of PFAS in manufacturing and product applications. Some examples include: Water and stain resistant coated fabrics, textiles, apparel, and footwear,  Surfactant applications including fume suppressants,  Refrigerants and coolants,  Fire suppressants, Fluoropolymers  Manufacturing processing aids,  Coated food packaging, and Other non-stick coated materials and products (e.g. dental floss, cookware, etc.) Funding Information The maximum funding amount for each research project is $35,000 per academic year Criteria Research funding is available for faculty and their graduate students from any academic institution located in Massachusetts.  For more information, visit TURI.

The purpose of this Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions is to support small scale research grants at institutions that do not receive substantial funding from the NIH, with an emphasis on providing biomedical research experiences primarily for undergraduate students, and enhancing the research environment at these applicant institutions. Eligible institutions must award baccalaureate science degrees, and have received less than 6 million dollars per year of NIH support (total costs) in 4 of the last 7 fiscal years.

This grant provides funding to nonprofit organizations and educational institutions in specific Pennsylvania counties to develop workforce skills and enhance economic development initiatives.

This Funding Opportunity Announcement (FOA) seeks innovative grant applications in nonmalignant hematology research that will steer the field in new directions. Applications to this FOA should propose proof of principle research that is tightly focused into one specific aim, which can be accomplished within a 1-3 year project period, and is directed at validating novel concepts and approaches that promise to open new pathways for discovery.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build research activities in nonmalignant hematology. This Funding Opportunity Announcement (FOA) is intended to promote innovative research projects in nonmalignant hematology that explore high impact and new directions of inquiry. While each Institute shares interests in nonmalignant hematology research, they also bring different perspectives, thereby expanding the scope of the SHINE II program beyond a single Institute's research mission. This "New Directions in Hematology Research (SHINE-II)" program invites investigator-initiated grant applications for basic or early translational, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to advance new pathways for discovery. This program may include clinical research involving human subjects that is directed at understanding disease pathogenesis and prognosis. Research applications submitted under this FOA should be more limited in scope (single aim with sub-aims, as appropriate) and duration (1-3 years) than typical R01 grant applications. The SHINE-II FOA seeks specifically to promote and support new directions of research in their early stages. Applications submitted to this FOA should include preliminary data that support the conceptual basis of the research proposed and the technical approaches to be used. Moreover, while research applications submitted under this FOA are expected to be more limited in scope and shorter in duration than typical R01 applications, achievement of the research objective(s) proposed should validate novel pathways of discovery and provide the basis for future high impact research endeavors. Principal areas of interest for this collaborative FOA include: (1) hematopoietic stem cell biology, (2) lineage fate determinants, (3) aging-related immune dysfunction and lymphocyte biology, (4) myeloid cell biology, and myelopoiesis, (5) platelet biology and dysfunction, (6) erythroid cell biology and erythropoiesis, (7) the molecular biology of heme and hemoglobin, (8) acquired and congenital disorders of red blood cell production and survival leading to chronic anemia or bone marrow failure, (9) and the uptake, utilization, storage, and transport of iron in health and disease. Inquiries to Scientific/Research staff prior to submission of an application to this FOA are strongly encouraged to discuss programmatic relevance and potential time tables for funding (see below, Section VII. Agency Contacts). The limited scope and shorter duration of the SHINE II R01 are not optimal for Early Stage Investigators (ESIs) and New Investigators (NIs), who should contact Scientific/Research staff prior to submission of an application to this FOA.

This funding opportunity supports educators in Lancaster County, Fort Lawn, and Great Falls, South Carolina, by providing financial resources for innovative and collaborative projects that enhance student learning.

The City of Boulder has released the 2025 Health Equity Fund (HEF) Request for Proposals, for community-based health equity programs benefitting Boulder community members experiencing health disparities. Donor Name: City of Boulder State: County: All Counties Type of Grant: Grant Deadline: (mm/dd/yyyy) 08/12/2024 Size of the Grant: $1000 to $10,000 Grant Duration: 3 Years Details: The Health Equity Fund aims to reduce disparities and to improve health equity for people experiencing systemic socio-economic and health barriers. Examples of HEF-supported programs include health services that help prevent obesity, diabetes, heart disease and oral diseases; increased access to healthy food and clean water; wellness programs; physical fitness; and more. The City of Boulder defines health equity as the absence of systematic health disparities based on socio-economic factors, and the ability of all residents to reach their full health potential, regardless of their life circumstances. Through the HEF, the City of Boulder funds health and wellness programs that benefit City of Boulder residents experiencing health disparities, including: Residents disproportionately impacted by diseases linked to sugar-sweetened beverage (SSB) consumption or disproportionately targeted by SSB marketing; Residents who lack access to healthy food, safe water, quality health care, wellness information and health care services and systems; and Populations systemically disenfranchised due to race, ethnicity, income, age, ability, sexual orientation or gender identification. Funding Information  Proposals must request a minimum of $10,000 with at least $8,000 in eligible expenses. Grant Period The RFP is for program services performed from January 1, 2025, to December 31, 2027. Eligibility Criteria Through the HEF, the city will fund programs rather than entire organizations, institutions, or agencies. Eligible programs may be implemented in nonprofit organizations, government agencies, or public or private educational institutions (i.e., preK-12 school or college/university). Businesses and for-profit agencies should not apply. Eligible program activities may include direct services, research or collaborative approaches.  Proposal Criteria Proposals will be evaluated based on whether the proposed program:  Benefits people most affected by, or at increased risk from chronic disease linked to sugary drink consumption, or who generally experience health disparities.  Has leadership (agency board, staff and volunteers) that reflects the demographic diversity of clients served. Aligns with a selected program priority. Demonstrates sound research, evidence-based best practices. Values lived experience, cultural knowledge and wisdom.  Demonstrates strong and long-term evaluation of outcomes, or potential for such evaluation. Meaningfully engages community members experiencing health disparities in the design, implementation and/or evaluation of the proposed program. Demonstrates strong collaboration and transformative, equitable partnerships that move beyond informal relationships. Demonstrates a cost-effective approach that benefits program participants, target populations or the community. Demonstrates that the agency currently has, or demonstrates a plan for achieving sustained financial stability and organizational leadership. Exhibits diverse funding sources or a plan to achieve diverse funding.  For more information, visit COB.

This Notice of Funding Opportunity (NOFO) seeks to support multidisciplinary research teams with complementary expertise in HIV and pathobiology, pathophysiology, and/or metabolism in organs, tissues, and/or biological systems of specific interest to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These teams will comprehensively interrogate fundamental biological mechanisms underlying HIV-associated comorbidities, co-infections, and complications relevant to the mission of the NIDDK and advance progress toward preventing or alleviating them.

The purpose of the NIH Research Conference Grant (R13) is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.

The United States Department of Agriculture (USDA) Food and Nutrition Service (FNS) works to end hunger and promote nutrition security. The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) is a Federal nutrition assistance program that serves pregnant, postpartum, and breastfeeding individuals, infants, and children up to five years old who are income eligible and at nutritional risk. WIC provides nutritious foods, nutrition education including breastfeeding promotion and support, and referrals to health and social services to participants in all 50 geographic states, the District of Columbia, 33 Indian Tribal Organizations (ITOs), and five U.S. territories (American Samoa, Guam, the Commonwealth of the Northern Mariana Islands, Puerto Rico, and the U.S. Virgin Islands). The Consolidated Appropriations Act, 2024 (The Act) (P.L. 117-2) provided the USDA with an appropriation to carry out the WIC Program as authorized by section 17 of the Child Nutrition Act of 1966 (CNA) (42 U.S.C. 1786). ARPA provided the USDA with $390 million to carry out outreach, innovation, and program modernization efforts to increase participation and redemption of benefits in WIC and the WIC Farmers Market Nutrition Program (FMNP). This is an announcement of the availability of funds for a one-time initiative, competitive cooperative agreement for up to four years. Funds are available to an entity (i.e., a civic technology nonprofit or other nonprofit type with similar staffing and experience/expertise; a research institute that is public, private, or nonprofit; or an accredited college or university) that meets the technical requirements outlined in this RFA. USDA anticipates awarding up to $15,000,000 to one selected applicant. The Period of Performance will be at a minimum two Fiscal Years will not exceed a maximum of four Fiscal Years.